Skip to main content

Your search for “MIS-C” returned 6 results

Kids With MIS-C Mount Normal T Cell Response to COVID-19

October 7, 2021

UC San Diego study suggests multisystem inflammatory syndrome in children (MIS-C), a rare condition associated with COVID-19, is not caused by abnormal T cell response to COVID-19 virus as previously hypothesized.

COVID-19, MIS-C and Kawasaki Disease Share Same Immune Response

May 16, 2022

COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.

Same Treatment Tested for Kids with Kawasaki Disease and Rare COVID-19 Reaction

October 26, 2021

Researchers at University of California San Diego School of Medicine tested the same treatment for kids with Kawasaki disease and rare COVID-19 reaction.

How to Tell the Difference between Kawasaki Disease and MIS-C

September 20, 2022

A national team of scientists, led by researchers at UC San Diego, have created a machine-learning algorithm for diagnosing both MIS-C and Kawasaki disease, two similar pediatric inflammatory conditions with different treatments.

Kawasaki Disease is not a Homogenous Disease nor are its Triggers

September 29, 2020

Researchers at UC San Diego report that while Kawasaki disease occurs in clusters, the traits, and thus the triggers of the inflammatory disease vary among clusters.

UC San Diego and Rady Children’s Hospital Join Nationwide Long-COVID Study

August 5, 2022

Researchers at University of California San Diego School of Medicine and Rady Children’s Hospital-San Diego have joined a nationwide study to better understand the long-term impact of COVID-19 on patients in the United States across all demographic groups.

Category navigation with Social links